↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

63 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   2387066   -   -   -   -   1件:
56 
 2   3400935113276   -   -   -   -   1件:
56 
 3   8699505952864   -   -   -   -   1件:
56 
 4   Adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 5   Ain457   -   -   -   -   7件:
13,
37,
41,
46,
56,
96,
271 
 6   Allogeneic stem cell transplant   -   -   -   -   2件:
53,
56 
 7   Alpha interferon   -   -   -   -   1件:
56 
 8   Anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   15件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
84,
86,
106,
107,
299 
 9   Apremilast   Apremilast   D08860   4件: PDE4A, PDE4B, PDE4C, PDE4D   2件: Purine metabolism, cAMP signaling pathway   5件:
46,
50,
56,
97,
271 
 10   Apremilast (cc-10004)   Apremilast   D08860   4件: PDE4A, PDE4B, PDE4C, PDE4D   2件: Purine metabolism, cAMP signaling pathway   1件:
56 
 11   Autologous stem cell transplant   -   -   -   -   2件:
53,
56 
 12   Autologous stem cell transplantation   -   -   -   -   2件:
56,
96 
 13   Butyrate   Butyric Acid   D05866   -   -   2件:
56,
291 
 14   Canakinumab   Canakinumab   D09315   1件: IL1B   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NOD-like receptor signaling pathway   9件:
46,
56,
84,
106,
107,
108,
113,
266,
269 
 15   Cc-10004   -   -   -   -   2件:
56,
271 
 16   Colchicine   Colchicine   D00570   9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   2件: Gap junction, Phagosome   5件:
2,
42,
56,
93,
266 
 17   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 18   Cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   16件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 19   Cyclosporin a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   11件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
113,
164 
 20   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 21   Cyclosporine pill   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
56 
 22   Cytotoxic combination   -   -   -   -   1件:
56 
 23   Daclizumab   Daclizumab   D03639   1件: IL2RA   4件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, JAK-STAT signaling pathway   7件:
13,
56,
60,
65,
97,
283,
284 
 24   Drug administration   -   -   -   -   1件:
56 
 25   Entecavir   Entecavir   D04008, D07896   -   -   5件:
46,
56,
96,
97,
271 
 26   Etanercept   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   14件:
15,
35,
38,
39,
46,
50,
53,
56,
60,
85,
228,
271,
285,
298 
 27   Etanercept, methotrexate, prednisolone   Etanercept, Methotrexate, Prednisolone   D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301   5件: DHFR, DHFR2, LTA, NR3C1, TNF   12件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Folate biosynthesis, MAPK signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, One carbon pool by folate, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
56 
 28   Flucinolone acetonide   -   -   -   -   1件:
56 
 29   Gevokizumab   Gevokizumab   D09911   1件: IL1B   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NOD-like receptor signaling pathway   4件:
41,
50,
56,
269 
 30   Gsk1070806   -   -   -   -   2件:
56,
96 
 31   Habitual diet   -   -   -   -   1件:
56 
 32   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 33   Il-2   Human interleukin-2, il-2   -   -   -   5件:
2,
46,
49,
56,
96 
 34   Ilaris   Canakinumab   D09315   1件: IL1B   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NOD-like receptor signaling pathway   6件:
56,
84,
106,
107,
108,
266 
 35   Infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 36   Interferon alfa   Interferon alfa   D03305   2件: IFNAR1, IFNAR2   8件: Cytokine-cytokine receptor interaction, Hepatitis B, Hepatitis C, JAK-STAT signaling pathway, Measles, Natural killer cell mediated cytotoxicity, Pathways in cancer, Toll-like receptor signaling pathway   5件:
25,
26,
28,
56,
96 
 37   Interferon alfa-2a   Interferon alfa   D03305   2件: IFNAR1, IFNAR2   8件: Cytokine-cytokine receptor interaction, Hepatitis B, Hepatitis C, JAK-STAT signaling pathway, Measles, Natural killer cell mediated cytotoxicity, Pathways in cancer, Toll-like receptor signaling pathway   1件:
56 
 38   Interferon-alpha2a   -   -   -   -   1件:
56 
 39   Interleukin 2   Human interleukin-2, interleukin 2   -   -   -   9件:
46,
49,
51,
56,
63,
95,
96,
97,
271 
 40   Intravitreal infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
56 
 41   J1081   -   -   -   -   1件:
56 
 42   Low-dose il-2   Human interleukin-2, il-2   -   -   -   1件:
56 
 43   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 44   Methylorednisolone   -   -   -   -   1件:
56 
 45   Oral butyrate   Butyric Acid   D05866   -   -   1件:
56 
 46   Pentoxifylline   Pentoxifylline   D00501   -   -   10件:
26,
56,
84,
93,
96,
113,
220,
222,
296,
298 
 47   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 48   Remicade   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   8件:
46,
49,
56,
84,
85,
96,
97,
271 
 49   Remicade 100 mg   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
56 
 50   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 51   Roferon-a 3miu   -   -   -   -   1件:
56 
 52   Roferon-a, 3miu   -   -   -   -   1件:
56 
 53   Roferon-a, 4.5miu   -   -   -   -   1件:
56 
 54   Roferon-a, 6miu   -   -   -   -   1件:
56 
 55   S78989   -   -   -   -   3件:
41,
50,
56 
 56   Subcutaneous ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
56 
 57   Ta-650   -   -   -   -   4件:
37,
56,
96,
97 
 58   Triamcinolone   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
35,
46,
56,
70,
90,
96,
226,
298 
 59   Triamcinolone acetonide   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
35,
46,
56 
 60   Ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   15件:
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 
 61   Vegetarian diet   -   -   -   -   1件:
56 
 62   Veldona,   -   -   -   -   1件:
56 
 63   Xoma 052   -   -   -   -   5件:
41,
46,
50,
56,
106 

先頭へ